Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
25.95
-0.83 (-3.10%)
At close: Aug 21, 2026
-22.79% (1Y)
| Market Cap | 9.52B -22.8% |
| Revenue (ttm) | 277.82M +452.9% |
| Net Income | -564.33M |
| EPS | -1.54 |
| Shares Out | 366.68M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,616,382 |
| Open | 26.28 |
| Previous Close | 26.78 |
| Day's Range | 25.77 - 26.75 |
| 52-Week Range | 20.07 - 37.88 |
| Beta | 0.64 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 31, 2026 |